Humanized anti-IL-2 receptor monoclonal antibody

· Facet Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Humanized anti-IL-2 receptor monoclonal antibody, covering 2009-07-20 to 2009-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis [Phase 2]